T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BSMX
326
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $340M | 0.07% |
31,091,819
+12,415,530
| +66% | +$133M |
|
327
Akamai
AKAM
$18B
| $339M | 0.07% |
4,767,028
+68,329
| +1% | +$4.52M |
|
328
Wheaton Precious Metals
WPM
$59.9B
| $337M | 0.07% |
17,728,596
+5,886,310
| +50% | +$125M |
|
|
ARG
329
DELISTED
Airgas Inc
ARG
| $336M | 0.07% |
3,163,018
-40,638
| -1% | -$4.61M |
|
330
Western Digital
WDC
$168B
| $335M | 0.07% |
4,875,428
-1,441,101
| -23% | -$113M |
|
331
Digital Realty Trust
DLR
$73.1B
| $334M | 0.07% |
5,065,605
+622,100
| +14% | +$42.7M |
|
|
CB
332
DELISTED
CHUBB CORPORATION
CB
| $333M | 0.07% |
3,292,485
-3,960
| -0.1% | -$401K |
|
|
MINI
333
DELISTED
Mobile Mini Inc
MINI
| $330M | 0.07% |
7,743,156
+35,100
| +0.5% | +$1.4M |
|
|
ATML
334
DELISTED
ATMEL CORP
ATML
| $326M | 0.07% |
39,562,268
+1,509,985
| +4% | +$12.7M |
|
335
Pricesmart
PSMT
$5.55B
| $325M | 0.07% |
3,821,690
+255,253
| +7% | +$21.2M |
|
|
MIK
336
DELISTED
Michaels Stores, Inc
MIK
| $324M | 0.07% |
11,959,623
+4,249,363
| +55% | +$113M |
|
|
WCN
337
Waste Connections
WCN
$41.6B
| $320M | 0.07% |
9,956,081
+3,312,227
| +50% | +$101M |
|
338
ConocoPhillips
COP
$150B
| $316M | 0.07% |
5,071,151
-101,626
| -2% | -$6.57M |
|
339
First Horizon
FHN
$12.3B
| $316M | 0.07% |
22,087,508
+45,537
| +0.2% | +$627K |
|
340
Boston Properties
BXP
$11B
| $313M | 0.06% |
2,229,163
+15,310
| +0.7% | +$2.14M |
|
341
Masco
MAS
$14.7B
| $311M | 0.06% |
13,272,447
-4,905
| -0% | -$111K |
|
342
Seagate
STX
$209B
| $310M | 0.06% |
5,956,120
+2,072,086
| +53% | +$123M |
|
|
WBC
343
DELISTED
WABCO HOLDINGS INC.
WBC
| $310M | 0.06% |
2,520,330
-243,816
| -9% | -$26.5M |
|
344
West Pharmaceutical
WST
$24.4B
| $309M | 0.06% |
5,132,510
+3,201,841
| +166% | +$171M |
|
345
Genuine Parts
GPC
$18.7B
| $303M | 0.06% |
3,256,296
+695
| +0% | +$67K |
|
346
Under Armour
UAA
$2.3B
| $302M | 0.06% |
7,485,116
-3,165,636
| -30% | -$116M |
|
|
BRCM
347
DELISTED
BROADCOM CORP CL-A
BRCM
| $300M | 0.06% |
6,932,957
+1,504,772
| +28% | +$65.6M |
|
348
Vail Resorts
MTN
$5.18B
| $298M | 0.06% |
2,882,720
+28,850
| +1% | +$2.61M |
|
349
eBay
EBAY
$46.5B
| $296M | 0.06% |
12,207,596
+2,497,937
| +26% | +$59.6M |
|
350
C.H. Robinson
CHRW
$17.5B
| $295M | 0.06% |
4,023,847
-381,142
| -9% | -$27.9M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.